Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Sep;30(Suppl 1):356-8.
doi: 10.1007/s12288-014-0404-2. Epub 2014 May 23.

Remission of microangiopathy in transplanted thalassemic child

Priya Marwah  1 , Rajpreet Soni  1 , Lawrence Faulkner  2 , Mohammed El Missiry  2 , Cornelio Uderzo  2
Affiliations
Case Reports

Remission of microangiopathy in transplanted thalassemic child

Priya Marwah et al. Indian J Hematol Blood Transfus. 2014 Sep.

Abstract

Transplant associated thrombotic microangiopathy is a severe complication of Hematopoeitic stem cell transplantation. Although there is agreement in terms of diagnostic criteria, treatment options are not clarified yet. We present a patient aged 2.6 years who developed transplant associated thrombotic microangiopathy after allogeneic bone marrow transplantation and to discuss both risk factors and possible spontaneous remission of transplant associated thrombotic microangiopathy.

Keywords: CMV infection; Cyclosporine; Microangiopathy; Transplantation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Correspondence
See this image and copyright information in PMC

References

    1. Ho VT, Cutler C, Carter S, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoetic stem cell transplantation. Biol Blood Marrow Transpl. 2005;11:571–575. doi: 10.1016/j.bbmt.2005.06.001. - DOI - PubMed
    1. Uderzo C, Bonanomi S, et al. Risk factors and severe outcome in Thrombotic Microangiopathy after allogeneic hematopoetic stem cell transplantation. Transplantation. 2006;82:638. doi: 10.1097/01.tp.0000230373.82376.46. - DOI - PubMed
    1. Cutler C, Henry NL, Magee C, et al. Sirolimus and thrombotic microangiopathy after allogeneic hematopoetic stem cell transplantation. Biol Blood Marrow Transpl. 2005;11:551–557. doi: 10.1016/j.bbmt.2005.04.007. - DOI - PubMed
    1. Stavrou E, Lazarus HM. Thrombotic microangiopathy in hematopoetic cell transplantation: an update. Mediterr J Hemat Infect Dis. 2010;2(3):e 2010033. doi: 10.4084/mjhid.2010.033. - DOI - PMC - PubMed
    1. Shimoni, et al. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced intensity conditioning. The incidence is not reduced. Biol Blood Marrow Transpl. 2004;10:484. doi: 10.1016/j.bbmt.2004.03.002. - DOI - PubMed

Publication types

LinkOut - more resources